248 related articles for article (PubMed ID: 12761131)
1. Attenuated Yersinia pseudotuberculosis carrier vaccine for simultaneous antigen-specific CD4 and CD8 T-cell induction.
Rüssmann H; Gerdemann U; Igwe EI; Panthel K; Heesemann J; Garbom S; Wolf-Watz H; Geginat G
Infect Immun; 2003 Jun; 71(6):3463-72. PubMed ID: 12761131
[TBL] [Abstract][Full Text] [Related]
2. Concomitant cytosolic delivery of two immunodominant listerial antigens by Salmonella enterica serovar typhimurium confers superior protection against murine listeriosis.
Igwe EI; Geginat G; Rüssmann H
Infect Immun; 2002 Dec; 70(12):7114-9. PubMed ID: 12438393
[TBL] [Abstract][Full Text] [Related]
3. "One size fits it all": translocation of foreign antigens by Yersinia type III secretion system (TTSS) leads to concomitant CD4 and CD8 T-cell priming.
Rüssmann H; Panthel K
Int J Med Microbiol; 2004 Oct; 294(5):313-7. PubMed ID: 15532990
[TBL] [Abstract][Full Text] [Related]
4. Induction of CD8+ T cell responses by Yersinia vaccine carrier strains.
Wiedig CA; Kramer U; Garbom S; Wolf-Watz H; Autenrieth IB
Vaccine; 2005 Oct; 23(42):4984-98. PubMed ID: 15985316
[TBL] [Abstract][Full Text] [Related]
5. Alternative endogenous protein processing via an autophagy-dependent pathway compensates for Yersinia-mediated inhibition of endosomal major histocompatibility complex class II antigen presentation.
Rüssmann H; Panthel K; Köhn B; Jellbauer S; Winter SE; Garbom S; Wolf-Watz H; Hoffmann S; Grauling-Halama S; Geginat G
Infect Immun; 2010 Dec; 78(12):5138-50. PubMed ID: 20876292
[TBL] [Abstract][Full Text] [Related]
6. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.
Rüssmann H; Igwe EI; Sauer J; Hardt WD; Bubert A; Geginat G
J Immunol; 2001 Jul; 167(1):357-65. PubMed ID: 11418671
[TBL] [Abstract][Full Text] [Related]
7. Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease.
Rüssmann H
Int J Med Microbiol; 2004 Apr; 293(7-8):565-9. PubMed ID: 15149032
[TBL] [Abstract][Full Text] [Related]
8. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella.
Verma NK; Ziegler HK; Wilson M; Khan M; Safley S; Stocker BA; Schoolnik GK
Vaccine; 1995 Feb; 13(2):142-50. PubMed ID: 7625107
[TBL] [Abstract][Full Text] [Related]
9. A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.
Zhang Y; Mena P; Romanov G; Lin JS; Smiley ST; Bliska JB
Infect Immun; 2012 Jan; 80(1):206-14. PubMed ID: 22064714
[TBL] [Abstract][Full Text] [Related]
10. A Recombinant Attenuated
Singh AK; Curtiss R; Sun W
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331960
[TBL] [Abstract][Full Text] [Related]
11. YopE specific CD8+ T cells provide protection against systemic and mucosal Yersinia pseudotuberculosis infection.
González-Juarbe N; Shen H; Bergman MA; Orihuela CJ; Dube PH
PLoS One; 2017; 12(2):e0172314. PubMed ID: 28207901
[TBL] [Abstract][Full Text] [Related]
12. Intracytoplasmic delivery of listeriolysin O by a vaccinal strain of Bacillus anthracis induces CD8-mediated protection against Listeria monocytogenes.
Sirard JC; Fayolle C; de Chastellier C; Mock M; Leclerc C; Berche P
J Immunol; 1997 Nov; 159(9):4435-43. PubMed ID: 9379042
[TBL] [Abstract][Full Text] [Related]
13. A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection.
Rodriguez-Del Rio E; Marradi M; Calderon-Gonzalez R; Frande-Cabanes E; Penadés S; Petrovsky N; Alvarez-Dominguez C
Vaccine; 2015 Mar; 33(12):1465-73. PubMed ID: 25659269
[TBL] [Abstract][Full Text] [Related]
14. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis.
Hess J; Gentschev I; Miko D; Welzel M; Ladel C; Goebel W; Kaufmann SH
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1458-63. PubMed ID: 8643654
[TBL] [Abstract][Full Text] [Related]
15. Expression of two Listeria monocytogenes antigens (P60 and LLO) in Lactococcus lactis and examination for use as live vaccine vectors.
Bahey-El-Din M; Casey PG; Griffin BT; Gahan CGM
J Med Microbiol; 2010 Aug; 59(Pt 8):904-912. PubMed ID: 20488938
[TBL] [Abstract][Full Text] [Related]
16. CCR2+ Inflammatory Dendritic Cells and Translocation of Antigen by Type III Secretion Are Required for the Exceptionally Large CD8+ T Cell Response to the Protective YopE69-77 Epitope during Yersinia Infection.
Zhang Y; Tam JW; Mena P; van der Velden AW; Bliska JB
PLoS Pathog; 2015 Oct; 11(10):e1005167. PubMed ID: 26468944
[TBL] [Abstract][Full Text] [Related]
17. Listeriolysin O-deficient Listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity.
Hamilton SE; Badovinac VP; Khanolkar A; Harty JT
J Immunol; 2006 Sep; 177(6):4012-20. PubMed ID: 16951364
[TBL] [Abstract][Full Text] [Related]
18. H2-M3-restricted T cells participate in the priming of antigen-specific CD4+ T cells.
Chow MT; Dhanji S; Cross J; Johnson P; Teh HS
J Immunol; 2006 Oct; 177(8):5098-104. PubMed ID: 17015693
[TBL] [Abstract][Full Text] [Related]
19. Yersinia enterocolitica Yop mutants as oral live carrier vaccines.
Leibiger R; Niedung K; Geginat G; Heesemann J; Trülzsch K
Vaccine; 2008 Dec; 26(51):6664-70. PubMed ID: 18822332
[TBL] [Abstract][Full Text] [Related]
20. Yersinia outer protein E, YopE. A versatile type III effector molecule for cytosolic targeting of heterologous antigens by attenuated Salmonella.
Rüssmann H
Adv Exp Med Biol; 2003; 529():407-13. PubMed ID: 12756799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]